샘플 요청 목록

 카트 문의
시장보고서
상품코드
1551540

세계의 소아 의약품 시장

Pediatric Medicines
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 387 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

소아용 의약품 세계 시장 규모는 2030년까지 1,790억 달러에 달할 것으로 전망

2023년 1,167억 달러로 추정되는 세계 소아용 의약품 시장은 2030년 1,790억 달러에 달할 것으로 예상되며, 2023-2030년의 분석 기간 동안 6.3%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 호흡기 질환 치료제는 CAGR 7.5%를 기록하며 분석 기간 종료 시점에 687억 달러에 달할 것으로 예상됩니다. 자가면역질환 치료제 부문은 분석 기간 동안 6.3%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 추정됩니다.

미국 시장은 318억 달러로 추정, 중국은 연평균 10.3%의 성장률로 성장할 것으로 전망

미국의 소아용 의약품 시장 규모는 2023년 318억 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 390억 달러 규모에 도달할 것으로 예상되며, 2023-2030년의 분석 기간 동안 10.3%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 2.6%와 6.4%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 4.0%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

세계 소아용 의약품 시장 - 주요 동향 및 촉진요인 요약

소아용 의약품은 어떻게 소아 의료에 혁명을 일으키고 있는가?

소아용 의약품은 영유아, 소아 및 청소년의 고유한 요구에 맞는 치료법을 제공함으로써 소아 건강 관리에 혁명을 일으키고 있습니다. 성인용 의약품과 달리 소아용 의약품은 어린이의 발달 중인 신체를 세심하게 고려하여 적절한 용량, 처방 및 투여 방법을 보장하기 위해 처방됩니다. 소아는 단순히 '작은 성인'이 아니라 체내 약물 처리가 다르기 때문에 성장, 장기 발달, 대사 속도를 고려한 독특한 제형이 필요하기 때문에 이러한 전문성은 매우 중요합니다. 소아 전용 의약품의 등장으로 귀 감염이나 천식 같은 흔한 소아 질환부터 소아 당뇨나 선천성 심장병과 같은 복잡한 만성 질환에 이르기까지 다양한 질환의 관리가 크게 개선되었습니다. 소아용 의약품은 안전하고 효과적이며 연령에 맞는 치료를 제공함으로써 아이들의 건강 관리의 질을 높이고 부작용을 줄이며 영유아기부터 사춘기까지 더 나은 건강 결과를 보장합니다.

어떤 혁신이 소아용 의약품의 기능을 향상시키고 있는가?

소아용 의약품의 혁신은 약물 제형, 전달 시스템 및 개인 맞춤형 의료의 발전을 통해 기능성을 향상시키고 있습니다. 가장 중요한 개발 중 하나는 액상 현탁액, 용해성 정제, 향이 첨가된 시럽제 등 어린이가 쉽게 복용할 수 있는 제형 개발입니다. 이러한 제제는 특히 정제를 삼키기 어렵거나 맛에 민감한 유아의 경우, 치료 요법을 준수하는 데 매우 중요합니다. 또한, 경피 패치나 흡입기와 같은 새로운 약물 전달 시스템은 기존 방식에 비해 투여가 용이하고 스트레스를 줄일 수 있는 비침습적 대안을 제공합니다. 소아과 영역에서도 개인 맞춤형 의료가 발전하고 있으며, 유전자 검사 및 바이오마커를 통해 개별 어린이의 유전적 프로파일에 맞는 치료가 가능해져 보다 효과적이고 안전한 치료를 보장할 수 있게 되었습니다. 또한, 약리유전체학의 발전으로 어린이가 특정 약물에 어떻게 반응할지를 예측할 수 있게 되어 의료진이 치료 계획을 최적화할 수 있게 되었습니다. 이러한 기술 혁신은 소아 의약품을 보다 접근하기 쉽고, 효과적이며, 어린이의 특성에 맞게 맞춤화하여 보다 정확하고 성공적인 의료 개입을 위한 길을 열어주고 있습니다.

소아용 의약품은 어린이의 건강 결과와 가족의 행복에 어떤 영향을 미칩니 까?

소아용 의약품은 질병 부담을 줄이고 어린이와 그 가족의 삶의 질을 향상시키는 효과적인 치료법을 제공함으로써 어린이의 건강 결과와 가족의 행복에 큰 영향을 미칩니다. 이러한 의약품은 어린이 특유의 의료 수요를 충족시켜 질병을 보다 효과적으로 예방 및 관리하고 입원, 응급 의료 및 장기적인 건강 합병증의 빈도와 심각성을 줄입니다. 이러한 건강 상태의 개선은 아이들의 신체적, 정서적, 사회적 발달에 필수적인 학교와 놀이와 같은 일상적인 활동에 더 많이 참여할 수 있도록 돕습니다. 가족은 안전하고 효과적인 소아 의약품을 이용할 수 있게 됨으로써 자녀의 질병 관리에 따른 스트레스와 불안을 줄이고, 자녀가 적절한 치료를 받고 있다는 안도감을 가질 수 있습니다. 또한, 잘 설계된 소아과 치료는 잦은 진료와 복잡한 의료 요법의 필요성을 줄이고 치료를 단순화하여 가족이 보다 정상적이고 안정된 일상생활을 유지할 수 있도록 돕습니다. 전반적으로, 소아과 의약품은 아이들의 건강과 행복을 지원하고, 더 건강한 다음 세대를 육성하고, 아픈 아이들을 돌보는 가족들이 직면한 어려움을 완화하는 데 매우 중요합니다.

소아용 의약품 시장의 성장을 가속하는 추세는?

소아용 의약품 시장의 성장을 가속하는 몇 가지 추세는 개인 맞춤형 의료에 대한 관심 증가, 소아 만성 질환 증가, 안전 및 규제 요건 강화 등 여러 가지가 있습니다. 특히, 개인 맞춤형 의료로의 전환은 개별 소아의 유전적, 생물학적 특성에 맞는 치료법을 개발하여 효능을 개선하고 부작용의 위험을 줄일 수 있기 때문에 큰 영향을 미치고 있습니다. 소아에서 천식, 비만, 당뇨병과 같은 만성 질환 증가는 이러한 질환을 장기적으로 관리하고 아이들이 질병에도 불구하고 건강한 삶을 영위할 수 있도록 도와주는 전문 의약품에 대한 수요를 촉진하고 있습니다. 또한, 소아용 의약품에 대한 안전성과 규제 요건에 대한 관심이 높아지면서 제약사들은 소아의 특수한 요구를 충족시키기 위해 엄격한 테스트와 제형 조정에 투자하고 있으며, FDA 및 EMA와 같은 규제 기관은 소아용 의약품 개발을 장려하는 가이드라인을 제정하고 새로운 치료법이 어린 환자들에게 안전하고 효과적일 수 있도록 새로운 치료법이 어린 환자들에게 안전하고 효과적이라는 것을 보장하기 위해 가이드라인을 제정했습니다. 이러한 추세는 의료 분야에서 소아 의료의 중요성이 점차 인식되고 있으며, 이 중요한 분야의 지속적인 확장과 기술 혁신이 어린이의 고유한 요구를 최상의 치료법으로 충족시킬 수 있도록 보장해야 한다는 점을 강조하고 있습니다.

조사 대상 기업 예시(총 51건)

  • AbbVie Inc.
  • AstraZeneca PLC
  • BioMarin Pharmaceutical Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb
  • Cipla Limited
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Helsinn Healthcare SA
  • Heron Therapeutics, Inc.
  • Jazz Pharmaceuticals plc
  • Novartis AG
  • Pfizer Inc.
  • PTC Therapeutics, Inc.
  • Sanofi SA
  • Sumitomo Pharma Co.
  • Teva Pharmaceutical Industries Ltd.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 24.10.04

Global Pediatric Medicines Market to Reach US$179.0 Billion by 2030

The global market for Pediatric Medicines estimated at US$116.7 Billion in the year 2023, is expected to reach US$179.0 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2023-2030. Respiratory Disorder Drugs, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$68.7 Billion by the end of the analysis period. Growth in the Autoimmune Disorder Drugs segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$31.8 Billion While China is Forecast to Grow at 10.3% CAGR

The Pediatric Medicines market in the U.S. is estimated at US$31.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$39.0 Billion by the year 2030 trailing a CAGR of 10.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Pediatric Medicines Market - Key Trends and Drivers Summarized

How Are Pediatric Medicines Revolutionizing Child Healthcare?

Pediatric medicines are revolutionizing child healthcare by providing tailored treatments that meet the specific needs of infants, children, and adolescents. Unlike adult medications, pediatric medicines are formulated with careful consideration of a child’s developing body, ensuring appropriate dosages, formulations, and administration methods. This specialization is crucial because children are not simply "small adults"; their bodies process drugs differently, requiring unique formulations that consider their growth, organ development, and metabolic rates. The availability of pediatric-specific medicines has significantly improved the management of a wide range of conditions, from common childhood illnesses like ear infections and asthma to more complex and chronic conditions such as juvenile diabetes and congenital heart defects. By providing safe, effective, and age-appropriate treatments, pediatric medicines are enhancing the quality of healthcare for children, reducing adverse drug reactions, and ensuring better health outcomes from infancy through adolescence.

What Innovations Are Enhancing the Functionality of Pediatric Medicines?

Innovations in pediatric medicines are enhancing functionality through advancements in drug formulations, delivery systems, and personalized medicine. One of the most significant developments is the creation of child-friendly formulations, such as liquid suspensions, dissolvable tablets, and flavored syrups, which make it easier for children to take their medications. These formulations are crucial for ensuring adherence to treatment regimens, especially for young children who may have difficulty swallowing pills or are sensitive to taste. Additionally, novel drug delivery systems, such as transdermal patches and inhalers, offer non-invasive alternatives that are easier to administer and reduce the stress associated with traditional methods. Personalized medicine is also making strides in pediatrics, with genetic testing and biomarker identification allowing for treatments that are tailored to the individual child’s genetic profile, ensuring more effective and safer therapies. Furthermore, advancements in pharmacogenomics are helping to predict how children will respond to specific medications, enabling healthcare providers to optimize treatment plans. These innovations are making pediatric medicines more accessible, effective, and aligned with the unique needs of children, paving the way for more precise and successful healthcare interventions.

How Do Pediatric Medicines Impact Child Health Outcomes and Family Well-being?

Pediatric medicines have a profound impact on child health outcomes and family well-being by providing effective treatments that reduce the burden of illness and improve the quality of life for both children and their families. By addressing the specific medical needs of children, these medicines help prevent and manage illnesses more effectively, reducing the frequency and severity of hospitalizations, medical emergencies, and long-term health complications. This improvement in health outcomes allows children to engage more fully in everyday activities, including school and play, which are essential for their physical, emotional, and social development. For families, the availability of safe and effective pediatric medicines alleviates the stress and anxiety associated with managing a child’s illness, providing peace of mind that their child is receiving appropriate care. Additionally, well-designed pediatric treatments can reduce the need for frequent doctor visits and complicated medical regimens, simplifying care and allowing families to maintain a more normal and stable routine. Overall, pediatric medicines are crucial in supporting the health and well-being of children, fostering a healthier future generation, and easing the challenges faced by families caring for sick children.

What Trends Are Driving Growth in the Pediatric Medicines Market?

Several trends are driving growth in the pediatric medicines market, including the increasing focus on personalized medicine, the rise of chronic diseases in children, and the growing emphasis on safety and regulatory requirements. The shift towards personalized medicine is particularly impactful, as it allows for the development of treatments that are tailored to the genetic and biological characteristics of individual children, improving efficacy and reducing the risk of adverse effects. The rise of chronic conditions such as asthma, obesity, and diabetes in children is also fueling demand for specialized medications that can manage these conditions over the long term, ensuring that children can lead healthier lives despite their illnesses. Additionally, there is a growing emphasis on safety and the regulatory requirements for pediatric medicines, which is driving pharmaceutical companies to invest in rigorous testing and formulation adjustments to meet the specific needs of children. Regulatory bodies like the FDA and EMA have established guidelines that encourage the development of pediatric-specific drugs, ensuring that new treatments are both safe and effective for young patients. These trends highlight the increasing recognition of the importance of pediatric medicine in healthcare and underscore the continued expansion and innovation in this critical area, ensuring that the unique needs of children are met with the best possible treatments.

Select Competitors (Total 51 Featured) -

  • AbbVie Inc.
  • AstraZeneca PLC
  • BioMarin Pharmaceutical Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb
  • Cipla Limited
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Helsinn Healthcare SA
  • Heron Therapeutics, Inc.
  • Jazz Pharmaceuticals plc
  • Novartis AG
  • Pfizer Inc.
  • PTC Therapeutics, Inc.
  • Sanofi SA
  • Sumitomo Pharma Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Pediatric Medicines - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Focus on Pediatric Health Boosts Development of Specialized Medicines
    • Rising Incidence of Chronic Diseases Among Children Driving Demand for Advanced Treatments
    • Expansion of Vaccine Programs and Their Impact on Pediatric Health
    • Technological Advances in Pediatric Diagnostic Tools
    • R&D Focus on Addressing Unmet Medical Needs in Pediatric Populations
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pediatric Medicines Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pediatric Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Pediatric Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Pediatric Medicines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Respiratory Disorder Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Respiratory Disorder Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Respiratory Disorder Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Autoimmune Disorder Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Autoimmune Disorder Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Autoimmune Disorder Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Gastrointestinal Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Gastrointestinal Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Gastrointestinal Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Drug Class by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Drug Class by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Drug Class by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Oral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Topical Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Topical Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Topical Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Parenteral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • JAPAN
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • CHINA
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • EUROPE
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Pediatric Medicines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Pediatric Medicines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Pediatric Medicines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • FRANCE
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • GERMANY
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Medicines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Pediatric Medicines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Pediatric Medicines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • INDIA
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: India 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: India 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Pediatric Medicines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Pediatric Medicines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Pediatric Medicines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Pediatric Medicines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Pediatric Medicines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Pediatric Medicines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • AFRICA
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제